FDA Label for Clemastine Fumarate
View Indications, Usage & Precautions
Clemastine Fumarate Product Label
The following document was submitted to the FDA by the labeler of this product Carilion Materials Management. The document includes published materials associated whith this product with the essential scientific information about this product as well as other prescribing information. Product labels may durg indications and usage, generic names, contraindications, active ingredients, strength dosage, routes of administration, appearance, warnings, inactive ingredients, etc.
Active Ingredient
Clemastine fumarate 1.34 mg (equivalent to 1 mg clemastine)
Purpose
Antihistamine
Keep Out Of Reach Of Children.
In case of overdose, get medical help or contact a Poison Control Center right away.
Uses
Temporarily relieves these symptoms of the common cold, hay fever, or other upper respiratory allergies:
- runny nose
- itchy, watery eyes
- sneezing
- itching of the nose or throat
Ask A Doctor Before Use If You Have
- glaucoma
- a breathing problem such as emphysema or chronic bronchitis
- trouble urinating due to an enlarged prostate gland
Ask A Doctor Or Pharmacist Before Use If You Are
taking sedatives or tranquilizers.
When Using This Product
- you may get drowsy
- avoid alcoholic drinks
- alcohol, sedatives, and tranquilizers may increase drowsiness
- be careful when driving a motor vehicle or operating machinery
- excitability may occur, especially in children
If Pregnant Or Breast-Feeding,
aska health professional before use.
Directions
adults and children 12 years and older: | 1 tablet every 12 hours; not more than 2 tablets in 24 hours |
children under 12 years: | ask a doctor |
Other Information
- Safety sealed: do not use if the imprinted bottle seal is open or torn.
- Store at 20°-25°C (68°-77°F).
Inactive Ingredients
Hydroxypropyl methylcellulose, lactose (monohydrate), magnesium stearate, microcrystalline cellulose, sodium starch glycolate, and starch (corn).
Questions Or Comments?
1-800-525-8747
* Please review the disclaimer below.